NEW YORK, April 3 – Compugen has licensed its new Gencarta database of annotated genomic, transcription, and proteomic data to Avalon Pharmaceuticals of Gaithersburg, MD, and has agreed to collaborate with Avalon on drug and diagnostic target identification research, the companies said Tuesday.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.